Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Unit to Help ADDNET Develop Urine-based Molecular Diagnostics for Renal Disease

NEW YORK, Dec. 15 (GenomeWeb News) - A unit of Ciphergen Biosystems will collaborate with the ADDNET consortium to create molecular diagnostics for kidney disease that relies on urine samples as opposed to traditional tissue biopsies, the company said today,


Existing blood and urine tests "cannot detect subclinical renal disease, and, although kidney biopsies are accurate, they are invasive and therefore cannot be a routine clinical test," the unit, Ciphergen Diagnostics, said in a statement.


As a result, the Sixth Framework Programme has funded this multi-year, multi-institution project to employ genomic, proteomic, and bioinformatics tools to "identify and validate a set of key molecular markers directly from patient urine that may yield novel diagnostic markers for the early and accurate non-invasive diagnosis of renal disease," the statement said.


Ciphergen Diagnostics will work with the ADDNET consortium, which is funded by the Sixth Framework Programme of the European Union. The consortium, which comprises six participants from four countries, is led by Harry Holthofer at the Universityof Helsinki.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.